Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 7 of 7 for “"CT20p"”.
-
The CT20 peptide as an agent for cancer treatment
… to treat metastatic disease, we discovered CT20p, an amphipathic peptide based on the C-terminus of Bax. Due to inherent properties of its sequence and similarity to antimicrobial peptides, CT20p is a promising cytotoxic agent whose activity is distinct from the parent protein (e.g. does not …
-
Folate conjugated hyperbranched polyester nanoparticles for prostate tumor-targeted delivery of a cytotoxic peptide via prostate specific membrane antigen
… that target prostate cancer tissue. To study CT20p as potential chemotherapeutic agent in the treatment of prostate cancer we proposed the use of targetable hyperbranched polyester (HBPE) based nanoparticles as delivery system. Folic acid was conjugated to the nanocarrier to improve the …
-
The Role of the Chaperone CCT in Assembling Cell Signaling Complexes
… increased chaperone capacity. The peptide CT20P has been shown to have cytotoxic effects in cancer cells, likely through its binding to CCT. We characterized CT20P, showing that it binds to CCT and inhibits its substrate-folding functions in cells. We specifically showed that a GFP-CT20P …
-
Chaperonin Containing TCP1 (CCT) as a Target for Cancer Therapy
… with decreased patient survival. We tested CT20p, the peptide therapeutic developed by our laboratory to inhibit CCT, on SCLC and primary lung cells, finding that CT20p was only cytotoxic to SCLC cells. Since SCLC currently lacks targeted therapeutics, our work yielded a new targeted agent …
-
The Dynamic Functions Of Bax Are Dependent On Key Structural And Regulatory Features
… A peptide based on the last twenty amino acids (CT20p) of the alpha-9 helix was synthesized and proved a potent inducer of cell death independent of any apoptotic stimuli. The solubility of CT20p allowed it to be encapsulated in polymeric nanoparticles (NPs), and these CT20p-NPs caused the death …
-
Chaperonin-containing TCP-1 Modulates Breast Cancer Growth and Malignancy
… phenotype. Finally, we used a CCT inhibitor, CT20p, to treat breast cancer cells and found it induces immunogenic cell death (ICD). ICD stimulates the immune system to attack the tumor cells and mice vaccinated with dying CT20p-treated cells did develop protective immunity against challenge …
-
Exploring the Mechanism of Chaperonin-Containing TCP-1 (CCT) as a Cancer Therapeutic
Cancer is one of the leading cause of mortality worldwide. Current anti-cancer therapeutics are approved for specific targets (e.g., ER, RAS, HER2). Despite initial favorable responses, cancer cells still acquire drug resistance and cross-tolerance to other treatments overtime. To address this …